Skip to Content
The biotechnology company produces medicines and treatments for allergic and inflammatory diseases, eye diseases, cancers, and more. Regeneron became a household name in 2020 when the U.S. government granted it a $450 million federal contract to develop an antibody drug to treat COVID-19. Former U.S. President Donald Trump reportedly received the treatment while hospitalized with the illness in October 2020.
Courtesy of Regeneron Pharmaceuticals.
Lists ranking Regeneron Pharmaceuticals
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
100 Fastest-Growing Companies - 2020Collectively, the ranked companies produced a thre...READ MOREview in list
Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list